Harlow John B. Jr. purchased $50K of LRMR
Harlow John B. Jr. (President and COO) purchased 17,800 shares of Larimar Therapeutics, Inc. (LRMR) at $2.80 on 2026-11-11.
How this was made
The 30-second read
Why it matters
The filing provides fresh information on insider confidence but limited market impact due to small size.
Market read
New insider purchase adds modest positive sentiment but unlikely to move the stock significantly.
What to watch
Potential upcoming clinical data could be the real driver, not the insider trade.
Background
Larimar Therapeutics filed a Form 4 showing an insider purchase.
Ticker impact
Form 4 disclosed President/COO bought 17,800 shares for $49,918, increasing his stake to 67,800 shares.
likely modest upward pressure as market prices in insider confidence
Purchase amount is modest ($50K) but insider role adds credibility; impact limited.
Market effects
Minimal effect on biotech sector; typical insider activity.
None
None
Counterpoint
The purchase is too small to signal material change; price may remain unchanged.
Key entities
- CompanyLarimar Therapeutics, Inc.
Biotech firm listed on Nasdaq (LRMR).
- PersonHarlow John B. Jr.
President and COO of Larimar Therapeutics.
